{"Differences":[{"Added medications":["Ursodeoxycholic acid (UDCA)","Antibiotics (e.g., ceftriaxone)","Pain relievers (e.g., acetaminophen)"]},{"Modified fields":[{"DrugName":"Ursodeoxycholic acid (UDCA)","Changes":{"Before":"Not present","After":"UDCA"},"Dosage":{"Before":"Not applicable","After":"300-600 mg orally twice a day with meals"},"AdminstrationRoute":{"Before":"Not applicable","After":"Oral"},"Notes":{"Before":"Not applicable","After":"Recommended for choledocholithiasis"}},{"DrugName":"Antibiotics (e.g., ceftriaxone)","Changes":{"Before":"Not present","After":"Antibiotics"},"Dosage":{"Before":"Not applicable","After":"IV or IM 1-2 grams once daily"},"AdminstrationRoute":{"Before":"Not applicable","After":"Intravenous or Intramuscular"},"Notes":{"Before":"Not applicable","After":"Important for pneumonia and duodenal perforation"}},{"DrugName":"Pain relievers (e.g., acetaminophen)","Changes":{"Before":"Not present","After":"Pain relievers"},"Dosage":{"Before":"Not applicable","After":"Take 500-1000 mg orally every 4-6 hours as needed"},"AdminstrationRoute":{"Before":"Not applicable","After":"Oral"},"Notes":{"Before":"Not applicable","After":"Essential for managing duodenal perforation and choledocholithiasis"}}]}],"Reflections":"The differences primarily involve the addition of medications crucial for the patient's conditions and the modifications in dosage, administration route, and notes to align with the specific diagnoses.","Guidance":["Trigger Condition: Patient diagnosed with conditions requiring specific medications (e.g., choledocholithiasis, pneumonia).","Recommended Action: Ensure appropriate medications are included in the prescription to address the diagnosed conditions.","Expected Outcome: Improved symptom management and targeted treatment for the patient's primary and secondary diagnoses."]}